Zobrazeno 1 - 10
of 14
pro vyhledávání: '"33"'
Autor:
Hikaru Miyamoto, Nobuhiro Izumi, Takuma Tsukioka, Ryuichi Ito, Hidetoshi Inoue, Noritoshi Nishiyama, Hiroaki Komatsu, T. Kimura
Publikováno v:
Anticancer Research. 41:2165-2169
In centrally-located lung cancer treatment, it is difficult to attain a sufficient resection margin. It is important to investigate recurrent styles in centrally-located lung cancer patients.Primary lung cancer located at the hilar area that requires
Autor:
Takashi Suzuki, Masato Kato, Genki Tanaka, Keiichi Kubota, Hidetsugu Yamagishi, Takatsugu Matsumoto, Johji Imura, Yuhki Sakuraoka, Takayuki Shimizu, Yukihiro Iso, Takayuki Shiraki, Taku Aoki, Takao Arakawa, Kyung Hwa Park, Kazuma Tago, Shozo Mori
Publikováno v:
Anticancer Research. 39:4315-4324
BACKGROUND/AIM This study aimed to obtain accurate differential diagnosis (DDx) of multicentric carcinogenesis (MC) and intrahepatic metastasis (IM) in recurrent lesions of hepatocellular carcinoma. MATERIALS AND METHODS A total of 79 patients who un
Autor:
Akihisa Matsuda, Satoshi Matsumoto, Kumiko Sekiguchi, Eriko Shinozuka, Hiroshi Yoshida, Hideyuki Suzuki, Nobuyuki Sakurazawa, Takeshi Yamada, Youichi Kawano
Publikováno v:
Anticancer Research. 39:4343-4350
Background/aim TAS-102 is recommended as salvage-line therapy for metastatic colorectal cancer (mCRC), but practical predictors for its efficacy are lacking. Patients and methods In a single-institutional retrospective study of 33 patients treated wi
Autor:
Azaz Ahmed, Niels Halama
Publikováno v:
Anticancer research. 40(11)
BACKGROUND/AIM The presence of TLS (tertiary lymphoid structures) is detectable in the microenvironment of human cancers and linked to better patient outcomes. The role of TLS in colorectal cancer liver metastases (CRCLM) is unclear. PATIENTS AND MET
Autor:
Valentina Ciaravino, Luca Landoni, Paola Vallerio, Sara Cingarlini, Aldo Scarpa, Stefano Crosara, Elisabetta Grego, Silvia Ortolani, Riccardo De Robertis, Mirko D'Onofrio, Claudio Bassi, Andrea Ruzzenente, Giampaolo Tortora
Publikováno v:
Anticancer Research. 37:1305-1312
Aim To evaluate modifications of perfusional parameters assessed by perfusion computed tomography (P-CT) of liver metastases (LM) from pancreatic neuroendocrine tumors (PanNETs) during everolimus treatment. Patients and methods All patients with LMs
Autor:
Florian Huemer, Richard Greil, Hanno Ulmer, Ewald Wöll, Lukas Weiss, Josef Thaler, Wolfgang Eisterer, Vera Trommet, Michael Hejna, Felix Keil, Birgit Gruenberger, Michael A. Fridrik
Publikováno v:
Anticancer Research. 37
Background/aim Although high response rates using the doublet-chemotherapy of oxaliplatin and irinotecan as well as its combination with cetuximab in advanced gastric cancer were shown in previous trials, time to progression was short, suggesting acq
Publikováno v:
Anticancer research. 37(8)
Background/aim The present study aimed to compare the utility of various inflammatory marker- and nutritional status-based prognostic factors, including many previous established prognostic factors, for predicting the prognosis of stage IV gastric ca
Autor:
Stephan, Mose, Christina, Stabik, Klaus, Eberlein, Ulla, Ramm, Heinz D, Böttcher, Kai, Budischewski
Publikováno v:
Anticancer research. 26(6C)
A carcinoma is the underlying cause of superior vena cava syndrome (SVCS) in 95-97% of patients. The aim of our study is to retrospectively analyse the outcome of patients after local radiotherapy compared to literature data.In 35 consecutively regis
Publikováno v:
Anticancer research. 19(2C)
Renal tumors resembling renal cell carcinoma but less than 3 cm in diameter historically have been regarded as adenomas because of their low frequency of metastases. However, this concept has been challenged, and it seems that all of these lesions sh
Autor:
K, Fujita, T, Kubota, S W, Matsuzaki, Y, Otani, M, Watanabe, T, Teramoto, K, Kumai, M, Kitajima
Publikováno v:
Anticancer research. 18(3B)
The chemosensitivity test using the MTT endpoint is useful in predicting chemosensitivity.One hundred twenty-eight patients with advanced gastric cancer were enrolled in the study, which mitomycin C (MMC), doxorubicin (DXR), 5-fluorouracil (5-FU), an